Rhythm Pharmaceuticals buy Royal Bank of Canada
Start price
18.02.26
/
50%
€85.50
Target price
18.02.27
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 18.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | - |
| iShares Core DAX® | 0.193% |
| iShares Nasdaq 100 | -1.353% |
| iShares Nikkei 225® | -0.426% |
| iShares S&P 500 | -1.008% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat